Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Russek-Blum Niva — NeuroSense Therapeutics Ltd. insider: 1 transactions · InsiderLens

Home / Insiders / Russek-Blum Niva

Russek-Blum Niva

Chief Technology Officer at NeuroSense Therapeutics Ltd. · on record since Mar 30, 2026

Insider trading activity of Russek-Blum Niva

Transactions on record: 1; since Mar 30, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Mar 30, 2026

Figures computed from official regulatory filings — methodology.

Companies where Russek-Blum Niva has traded

NeuroSense Therapeutics Ltd.1 tx · Mar 30, 2026

Track record of Russek-Blum Niva

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Russek-Blum Niva

Co-insiders of Russek-Blum Niva

Ben-Noon AlonNeuroSense Therapeutics Ltd.
Binder HagitNeuroSense Therapeutics Ltd.
Claiborne Cary JNeuroSense Therapeutics Ltd.
Eisenberg OrNeuroSense Therapeutics Ltd.
Golan RoyNeuroSense Therapeutics Ltd.
Leuchtenberger MarkNeuroSense Therapeutics Ltd.
Mandil-Levin RevitalNeuroSense Therapeutics Ltd.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

PELLIZZARI CHRISTINE ANeuroSense Therapeutics Ltd.

Tracik FerencNeuroSense Therapeutics Ltd.

Company	Filed	Type	Qty	Price	Value · USD	Src
NeuroSense Therapeutics Ltd.	Mar 30, 2026	Award	200,000	0.00 USD	$0	SEC